ThermoDox: Clinical Trials

2 trials of ThermoDox, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated, 1 withdrawn. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 1, Withdrawn 1

Follow ThermoDox: new trials by email Literature Review of ThermoDox trials Research Report on ThermoDox

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors
Magnetic Resonance-Guided High Intensity Focused Ultrasound, Lyso-thermosensitive Liposomal Doxorubicin - Solid Tumors, Soft Tissue Sarcoma
Phase 2WithdrawnChildren's National Research Institute2022-11-102025-01-01
Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC)
Lyso-Thermosensitive Liposomal Doxorubicin, 5% Dextrose Solution, ThermoDox - Colon Cancer Liver Metastasis
Phase 2TerminatedImunon22011-09-012022-10-13

Conditions studied

Carcinoma (1)  ·  Carcinoma, Hepatocellular (1)  ·  Colonic Neoplasms (1)  ·  Liver Neoplasms (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Recurrence (1)  ·  Rhabdomyosarcoma (1)  ·  Sarcoma (1)  ·  Sarcoma, Ewing (1)  ·  Wilms Tumor (1)

Sponsors

Children's National Research Institute (1)  ·  Imunon (1)

Countries

United States (2)

Top investigators

AeRang Kim, MD, PhD (1)  ·  Nicholas Borys, M.D. (1)